Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

Macular degeneration is the leading cause of blindness in developed countries. In the treatment of neovascular age-related macular degeneration, vascular endothelial growth factor (VEGF) has emerged as a key target for therapy. The intravitreal injection of anti-VEGF drugs has been widely employed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventrice, Pasquale, Leporini, Christian, Aloe, Jose’ Francisco, Greco, Ettore, Leuzzi, Giacomo, Marrazzo, Giuseppina, Scorcia, Giovanni Battista, Bruzzichesi, Donatella, Nicola, Varano, Scorcia, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853666/
https://www.ncbi.nlm.nih.gov/pubmed/24347979
http://dx.doi.org/10.4103/0976-500X.120947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853666/
https://www.ncbi.nlm.nih.gov/pubmed/24347979
http://dx.doi.org/10.4103/0976-500X.120947

Ejemplares similares